Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kathleen J. Yost"'
Autor:
Guila Delouya, Marvin Feldman, Jennifer Moughan, Rex B. Mowat, Yuhchyau Chen, Rakesh Gaur, Samir Narayan, John P. Hayes, William F. Regine, Joshua E. Meyer, John P. Hoffman, David L. Sherr, Edgar Ben-Josef, Thomas A. DiPetrillo, Howard Safran, Christopher H. Crane, Richard A. Peterson, Marsha Reyngold, Kathryn Winter, John H. Suh, Michael G. Haddock, Kathleen J. Yost, Ross A. Abrams, Ivan L. Kessel
Publikováno v:
The Oncologist. 25:e477-e483
Background Several registry-based analyses suggested a survival advantage for married versus single patients with pancreatic cancer. The mechanisms underlying the association of marital status and survival are likely multiple and complex and, therefo
Autor:
Kathleen J. Yost, Emile E. Voest, Katherine A. Janeway, Ajjai Alva, Edward S. Kim, Richard L. Schilsky, Philip J. Stella, Suanna S. Bruinooge, Pam K. Mangat, Navin R. Pinto, Elizabeth Garrett-Mayer, Susan Halabi, Jane Perlmutter
Publikováno v:
JCO Precision Oncology. :1-14
Purpose Case reports and small prospective trials suggest that administering targeted therapies to patients with advanced cancer and an identified genomic target may be associated with clinical benefit. The Targeted Agent and Profiling Utilization Re
Autor:
Sharad A. Ghamande, Jay W. Carlson, Allan Covens, Micael Lopez-Acevedo, Brittany A. Davidson, Edward J. Tanner, Jane M. Armer, Mark V. Schaverien, Sheila H. Ridner, Alphonse G. Taghian, Barbara Coyle, Jeannette Zucker, Leslie G. Ford, Leigh C. Ward, Jeanne Carter, Cheryl L. Brunelle, Kathryn H. Schmitz, Electra D. Paskett, Kathleen J. Yost, Worta McCaskill-Stevens, Stephanie L. Pugh, Joan L. Walker, Danielle Enserro, Andrea L. Cheville, Sandi Hayes, Sandra A. Russo, Michael Bernas
Publikováno v:
Gynecol Oncol
Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91fbfdcd27d746a4e064ed90fb72ccac
https://europepmc.org/articles/PMC7946397/
https://europepmc.org/articles/PMC7946397/
Autor:
Rahma Warsame, Carrie A. Thompson, S. Vincent Rajkumar, Thomas E. Witzig, Thomas M. Habermann, Kathleen J. Yost, Gita Thanarajasingam, Morie A. Gertz, James R. Cerhan, Surbhi Sidana, Stephen M. Ansell, Cristine Allmer, Shaji Kumar, Wilson I. Gonsalves, Angela Dispenzieri, Amylou C. Dueck, Yi Lin, Melissa C. Larson, Jonas Paludo, Grzegorz S. Nowakowski
Publikováno v:
Journal of Clinical Oncology. 38:e19112-e19112
e19112 Background: We sought to study the longitudinal QOL, financial burden and perception of care (PoC) in patients with multiple myeloma (MM) or lymphoma (LYM) enrolled on CTs vs. those receiving standard care (Non-CT). Methods: QOL was evaluated
Autor:
Kathleen J. Yost, David K. Edwards, Christine R Kirt, Bonny Kneedler, Amy L. Weaver, Jennifer J Laffin, Jennifer L. St. Sauver, Lila J. Finney Rutten, Emily J Kirsch, Janet E. Olson
Publikováno v:
BMJ Open Gastroenterology, Vol 7, Iss 1 (2020)
BMJ Open Gastroenterology
BMJ Open Gastroenterology
IntroductionPopulation-level screening has been shown to reduce the incidence and mortality of colorectal cancer (CRC). Unfortunately, adherence to screening recommendations among eligible US adults remains below national goals. A relatively new non-
Autor:
Jonathan W. Friedberg, Izidore S. Lossos, Loretta J. Nastoupil, Thomas M. Habermann, Kathleen J. Yost, Giorgio Inghirami, Christopher R. Flowers, Francisco Vega, John P. Leonard, Andrew L. Feldman, Julianne Lunde, James R. Cerhan, Brad S. Kahl, Richard Burack, Carla Casulo, Karen P. Mann, Leon Bernal-Mizrachi, Kiran Vij, Sergei Syrbu, Timothy J. McDonnell, Brian K. Link, Matthew J. Maurer, David L. Jaye, Peter Martin, Carrie A. Thompson, Cristine Allmer, Susan L. Slager
Publikováno v:
Blood. 132:1702-1702
Background: To address the current and long-term unmet health needs of the growing population of patients diagnosed with non-Hodgkin lymphoma (NHL) and NHL survivors, we established the Lymphoma Epidemiology of Outcomes (LEO) cohort study (NCT0273635
Autor:
E, Safroneeva, M, Coslovsky, C E, Kuehni, M, Zwahlen, N A, Haas, R, Panczak, T H, Taft, I, Hirano, E S, Dellon, N, Gonsalves, J, Leung, C, Bussmann, J T, Woosley, P, Yan, Y, Romero, G T, Furuta, S K, Gupta, S S, Aceves, M, Chehade, A, Straumann, A M, Schoepfer, Kathleen J, Yost
Publikováno v:
Alimentary Pharmacology and Therapeutics, vol 42, iss 8
Alimentary pharmacology & therapeutics, vol 42, iss 8
Alimentary pharmacology & therapeutics, vol 42, iss 8
Background Knowledge about determinants of quality of life (QoL) in eosinophilic oesophagitis (EoO) patients helps to identify patients at risk of experiencing poor QoL and to tailor therapeutic interventions accordingly. Aim To evaluate the impact o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b03c35cbdb96bfeb73030ecb259209
https://escholarship.org/uc/item/2hx3z59z
https://escholarship.org/uc/item/2hx3z59z
Autor:
James H. Doroshow, Patrick W. Cobb, James L. Abbruzzese, John S. Macdonald, Sheryl McCoy, Taral Patel, Brian F. Issell, Kathleen J. Yost
Publikováno v:
Investigational New Drugs. 24:537-542
From February, 2001 to September, 2002, the Southwest Oncology Group (SWOG) accrued 65 patients with advanced gastric adenocarcinoma to a phase II trial of weekly 5-FU, leucovorin, and the orally-administered uridine analog PN401. Of these 65 patient
Autor:
Emily Kern, Glenn T. Furuta, Radoslaw Panczak, Felicity Enders, Marcel Zwahlen, Elisabeth Maurer, Sandeep K. Gupta, Kathleen J. Yost, Evan S. Dellon, Jeffrey A. Alexander, Seema S. Aceves, Mirna Chehade, Nirmala Gonsalves, Christian Bussmann, Tiffany Taft, Margaret H. Collins, Nadine A. Haas, Claudia E. Kuehni, Yvonne Romero, Alex Straumann, Ekaterina Safroneeva, John Leung, Alain M. Schoepfer, Ikuo Hirano, Michael Coslovsky, Fouad J. Moawad, Peter Netzer
Publikováno v:
Gastroenterology, vol 147, iss 6
Gastroenterology
Gastroenterology, vol. 147, no. 6, pp. 1255-1266.e21
Gastroenterology
Gastroenterology, vol. 147, no. 6, pp. 1255-1266.e21
BACKGROUND & AIMS: Standardized instruments are needed to assess the activity of eosinophilic esophagitis (EoE) and to provide end points for clinical trials and observational studies. We aimed to develop and validate a patient-reported outcome (PRO)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dbc3337f2b19227931b48eb948c2def
https://escholarship.org/uc/item/8g87x8jd
https://escholarship.org/uc/item/8g87x8jd
Autor:
John Z. Ayanian, A. Chawla, Kathleen J. Yost, David T. Eton, Dee W. West, David Cella, Eric Holmgren
Publikováno v:
Journal of Clinical Epidemiology. 58:1241-1251
Objective To estimate minimally important differences (MIDs) on the Functional Assessment of Cancer Therapy–Colorectal (FACT-C) instrument using anchor- and distribution-based methods. Study Design and Setting Preliminary MIDs were generated for FA